2026 NPPES data Dermatology Physician NPI 1427370352 M.D.
Verify on CMS →

ADAM INGRAFFEA, M.D.

Dermatology Physician in CARY, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
730
Medicare Part D claims · 569 beneficiaries · Dermatology Physician avg: 729
MIPS score
94.3403/100
▲ 11 pts above national avg 83.1 · [object Object]

What the federal data shows

ADAM INGRAFFEA, M.D. reported a CMS MIPS final score of 94.3403/100 — above the 83.1 national average — and filed 730 Medicare Part D claims in 2023.

94.3403/100
MIPS score · +11 vs avg
730
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ADAM INGRAFFEA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ADAM INGRAFFEA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ADAM INGRAFFEA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 02/19/2010

NPI 1427370352

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

730 0% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

94.3403/100 11.240300000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in North Carolina

How Dermatology Physician compares to other specialties among North Carolina providers

North Carolina providers

Dermatology Physician share within North Carolina

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within North Carolina

Medicare quality performance — MIPS

ADAM INGRAFFEA, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
94.3403/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 94.3403/100 vs national avg 83.1

0%100%National avg83%94.3%
MIPS final score (Dermatology Physician) — 94.3403/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ADAM INGRAFFEA, M.D. is a Dermatology Physician provider practicing in CARY, North Carolina, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1427370352. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ADAM INGRAFFEA, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 200 WELLESLEY TRADE LN, CARY, NC, 27519, with a listed phone of (919) 363-7546. NPI 1427370352 was issued on 02/19/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what INGRAFFEA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 730 prescription claims written by this provider, covering 569 Medicare beneficiaries and totaling roughly $11K in drug spend, with an opioid prescribing rate of 6.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.3403/100 for the 2023 performance year (Quality 93.4383, Cost 89.8833), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 WELLESLEY TRADE LN
CARY, NC 27519

Provider Details

NPI 1427370352
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 02/19/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.3403
Final Score
Avg: 83.1
93.4383
Quality
89.8833
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where ADAM INGRAFFEA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CARY SKIN CENTER PA
CARY, NC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

730
Total Claims
$11K
Total Drug Cost
569
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
730
Total Day Supply
5,452
Generic Drug Cost
$9K
Opioid Claims
45 (6.2% rate)
Antibiotic Claims
666

Patient Demographics

Average Patient Age
77.0 years
Avg HCC Risk Score
1.22
Gender Split
38% female / 62% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Doxycycline Hyclate
626
Tramadol Hcl
45
Ciprofloxacin Hcl
13
Clindamycin Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How ADAM INGRAFFEA, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

ADAM INGRAFFEA, M.D.'s 730 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as INGRAFFEA.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ADAM INGRAFFEA, M.D.'s specialty?
ADAM INGRAFFEA, M.D. specializes in Dermatology Physician and practices in CARY, North Carolina. Credentials: M.D..
How much does ADAM INGRAFFEA, M.D. prescribe under Medicare Part D?
In 2023, ADAM INGRAFFEA, M.D. wrote 730 Medicare Part D claims totaling $11K in drug costs for 569 beneficiaries.
What is ADAM INGRAFFEA, M.D.'s Medicare quality score?
ADAM INGRAFFEA, M.D. has a CMS MIPS Final Score of 94.3403/100 (Quality: 93.4383, Cost: 89.8833). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ADAM INGRAFFEA, M.D. located?
ADAM INGRAFFEA, M.D. is located at 200 WELLESLEY TRADE LN, CARY, NC, 27519. Phone: (919) 363-7546.
What is ADAM INGRAFFEA, M.D.'s NPI number?
ADAM INGRAFFEA, M.D.'s National Provider Identifier (NPI) is 1427370352, issued on 02/19/2010.
Does ADAM INGRAFFEA, M.D. prescribe opioids?
Yes, ADAM INGRAFFEA, M.D. had 45 opioid claims in 2023 with an opioid prescribing rate of 6.2%.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does ADAM INGRAFFEA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ADAM INGRAFFEA, M.D.'s most frequently prescribed drugs include Doxycycline Hyclate, Tramadol Hcl, Ciprofloxacin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ADAM INGRAFFEA, M.D. accept Medicare?
ADAM INGRAFFEA, M.D. appears in CMS Medicare data with 730 Part D claims and 569 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ADAM INGRAFFEA, M.D.'s credentials?
ADAM INGRAFFEA, M.D.'s NPI is 1427370352 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology